Anti-Rabies Serum Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of theAnti-Rabies Serum Market?
The escalating occurrences of canine attacks anticipated to accelerate the expansion of the anti-rabies serum industry. Dog attacks involve injuries resulted from a dog biting or scratching an individual, severity ranging from minor to extreme. These attacks can result in infections, severe injuries, and in certain cases, convey diseases like rabies. Effective safeguarding and instant medical attention are vital for controlling and diminishing the perils associated with dog assaults. The occurrences of increased dog attacks are due to various factors such as the rise in urbanization leading to increased interactions between humans and dogs, a larger number of uncontrolled or inadequately trained dogs, and insufficient understanding or education about canine behavior and bite deterrence. The increasing prevalence of dog attacks has led to a strong demand for anti-rabies serum, as punctual administration of the serum is critical for thwarting the commencement of rabies in individuals exposed to potentially diseased animals. For example, in 2023, as per the American Veterinary Medical Association, a non-profit organization based in the US, the average expense for dog bite insurance claims in 2023 was $58,545. Insurers settled $1.12B in liability claims related to dog attacks and other dog-related injuries in 2023. Dog bite claims surged by almost 10% in 2023. Thus, the rising prevalence of dog attacks is propelling the expansion of the anti-rabies serum industry.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp
#How Does the ProjectedAnti-Rabies Serum Market Growth Compare Over the Forecast Period?
The market size for anti-rabies serum has seen significant growth in the past few years. The forecast predicts that it will expand from a value of $1.42 billion in 2024 to reach $1.5 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. Several factors have contributed to this growth during the historical period; there has been an increase in animal populations, enhancements to vaccination strategies, advancements in diagnostic methods, a rise in travel and migration, and increased public health initiatives and a greater frequency of human-wildlife interactions.
The market for anti-rabies serum is predicted to experience significant expansion in the coming years. The market is set to surge to $1.85 billion in 2029, with a compound annual growth rate (CAGR) of 5.4%. The anticipated growth during the forecast period can be tied to factors such as a surge in animal bite cases, augmented investments in rabies research, heightened understanding about diseases transmitted from animals to humans, betterment in serum storage and management, and increased backing for rabies mitigation initiatives. Recognizable trends for the forecast period comprise the creation of novel serum formulations, progress in healthcare facilities, technological enhancements in serum manufacturing, alternatives in delivery systems, and the conception of swift diagnostic kits.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20468
What Are the Latest Innovations Influencing theAnti-Rabies Serum Market?
Leading firms in the anti-rabies serum market are forming strategic partnerships to improve product development and expand their market presence. This refers to a practice where companies draw upon each other’s capabilities and resources for collective benefits and accomplishment. For instance, in July 2023, the US-based biopharmaceutical entity, Kedrion S.p.A, collaborated with Kamada, a biopharmaceutical firm based in Israel, to distribute KEDRAB (Rabies Immune Globulin [Human]) within the US. This alliance played a key role in co-developing and obtaining the product’s license in the U.S., along with spreading awareness about the disease. The collaboration has been instrumental in protecting people who have been exposed to dangerous animal bites from severe, potentially deadly circumstances.
Who Are the Major Industry Players Accelerating Growth in theAnti-Rabies Serum Market?
Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd ., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report
Which Primary Segments of the Anti-Rabies Serum Market Are Driving Growth and Industry Transformations?
The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals
Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20468&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theAnti-Rabies Serum Market?# Market?
North America was the largest region in the anti-rabies serum market in 2024. The regions covered in the anti-rabies serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Anti-Rabies Serum Market 2025, By The Business Research Company:
Rabies Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report
Animal Therapeutics And Diagnostics Global Market Report 2025
Anti-Inflammatory Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
